Iatrogenic pseudoaneurysm after bevacizumab therapy in patients with metastatic colorectal cancer: Two case reports

por Li, Ching-Chun, Tsai, Hsiang-Lin, Huang, Ching-Wen, Yeh, Yung-Sung, Tsai, Tzu-Hsueh, Wang, Jaw-Yuan
Publicado 2018

Unknown‑primary neuroendocrine neoplasms diagnosed by short‑acting somatostatin test: Case series in one institution

por Chang, Tsung-Kun, Su, Wei-Chih, Chen, Yen-Cheng, Chen, Po-Jung, Li, Ching-Chun, Yeh, Yung-Sung, Huang, Ching-Wen, Tsai, Hsiang-Lin, Wang, Jaw-Yuan
Publicado 2022

Effects of the number of neoadjuvant therapy cycles on clinical outcomes, safety, and survival in patients with metastatic colorectal cancer undergoing metastasectomy

por YEH, YUNG-SUNG, TSAI, HSIANG-LIN, CHEN, YEN-CHENG, SU, WEI-CHIH, CHEN, PO-JUNG, CHANG, TSUNG-KUN, LI, CHING-CHUN, HUANG, CHING-WEN, WANG, JAW-YUAN
Publicado 2023

Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiothe...

por Huang, Chun-Ming, Huang, Ming-Yii, Tsai, Hsiang-Lin, Huang, Ching-Wen, Su, Wei-Chih, Chang, Tsung-Kun, Chen, Yen-Cheng, Li, Ching-Chun, Wang, Jaw-Yuan
Publicado 2021

Comparison of UGT1A1 Polymorphism as Guidance of Irinotecan Dose Escalation in RAS Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIR...

por Tsai, Hsiang-Lin, Chen, Yen-Cheng, Yin, Tzu-Chieh, Su, Wei-Chih, Chen, Po-Jung, Chang, Tsung-Kun, Li, Ching-Chun, Huang, Ching-Wen, Wang, Jaw-Yuan
Publicado 2022

Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous UGT1A1*28 polymorphism: a single-center case series

por Tsai, Hsiang-Lin, Chen, Po-Jung, Chen, Yen-Cheng, Li, Ching-Chun, Chang, Tsung-Kun, Su, Wei-Chih, Yin, Tzu-Chieh, Huang, Ching-Wen, Wang, Jaw-Yuan
Publicado 2022

Observational Study Comparing Efficacy and Safety between Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy for Patients with Unresectable Locally Advanced or Metastatic Ga...

por Yeh, Yung-Sung, Huang, Ming-Yii, Ma, Cheng-Jen, Huang, Ching-Wen, Tsai, Hsiang-Lin, Chen, Yen-Cheng, Li, Ching-Chun, Yu, Fang-Jung, Shih, Hsiang-Yao, Wang, Jaw-Yuan
Publicado 2020

Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I–III rectal cancer undergoing preoperative chemoradiotherapy

por Huang, Ching-Wen, Su, Wei-Chih, Yin, Tzu-Chieh, Chen, Po-Jung, Chang, Tsung-Kun, Chen, Yen-Cheng, Li, Ching-Chun, Hsieh, Yi-Chien, Tsai, Hsiang-Lin, Wang, Jaw-Yuan
Publicado 2020

Oncological Outcomes of Robotic-Assisted Surgery With High Dissection and Selective Ligation Technique for Sigmoid Colon and Rectal Cancer

por Yin, Tzu-Chieh, Su, Wei-Chih, Chen, Po-Jung, Chang, Tsung-Kun, Chen, Yen-Cheng, Li, Ching-Chun, Hsieh, Yi-Chien, Tsai, Hsiang-Lin, Huang, Ching-Wen, Wang, Jaw-Yuan
Publicado 2020

Feasibility of robot-assisted surgery in elderly patients with rectal cancer

por Su, Wei-Chih, Huang, Ching-Wen, Ma, Cheng-Jen, Chen, Po-Jung, Tsai, Hsiang-Lin, Chang, Tsung-Kun, Chen, Yen-Cheng, Li, Ching-Chun, Yeh, Yung-Sung, Wang, Jaw-Yuan
Publicado 2021

Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer

por Huang, Ching-Wen, Chen, Yen-Cheng, Yin, Tzu-Chieh, Chen, Po-Jung, Chang, Tsung-Kun, Su, Wei-Chih, Ma, Cheng-Jen, Li, Ching-Chun, Tsai, Hsiang-Lin, Wang, Jaw-Yuan
Publicado 2021

miRNA-148a Enhances the Treatment Response of Patients with Rectal Cancer to Chemoradiation and Promotes Apoptosis by Directly Targeting c-Met

por Huang, Chun-Ming, Huang, Ming-Yii, Chen, Yen-Cheng, Chen, Po-Jung, Su, Wei-Chih, Chang, Tsung-Kun, Li, Ching-Chun, Huang, Ching-Wen, Tsai, Hsiang-Lin, Wang, Jaw-Yuan
Publicado 2021

Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer

por Chen, Yen-Cheng, Tsai, Hsiang-Lin, Li, Ching-Chun, Huang, Ching-Wen, Chang, Tsung-Kun, Su, Wei-Chih, Chen, Po-Jung, Yin, Tzu-Chieh, Huang, Chun-Ming, Wang, Jaw-Yuan
Publicado 2021

BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in BRAF-Mutated Metastatic Colorectal Cancer—A Case Series Study Target Therapy of BRAF-Mutated mCRC

por Yeh, Jen-Hao, Tsai, Hsiang-Lin, Chen, Yen-Cheng, Li, Ching-Chun, Huang, Ching-Wen, Chang, Tsung-Kun, Su, Wei-Chih, Chen, Po-Jung, Liu, Yu-Peng, Wang, Jaw-Yuan
Publicado 2021

Effectiveness and Cost-Utility Analysis of Different Doses of Irinotecan Plus Bevacizumab in Patients With Metastatic Colorectal Cancer: A Long-Term and Prospective Cohort Study

por Shi, Hon-Yi, Chen, Yen-Cheng, Huang, Ching-Wen, Li, Ching-Chun, Su, Wei-Chih, Chang, Tsung-Kun, Chen, Po-Jung, Yin, Tzu-Chieh, Tsai, Hsiang-Lin, Wang, Jaw-Yuan
Publicado 2022

Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to UGT1...

por Li, Ching-Chun, Chang, Tsung-Kun, Chen, Yen-Cheng, Tsai, Hsiang-Lin, Huang, Ching-Wen, Su, Wei-Chih, Ma, Cheng-Jen, Yin, Tzu-Chieh, Chen, Po-Jung, Wang, Jaw-Yuan
Publicado 2022

Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy

por Yin, Tzu-Chieh, Chen, Po-Jung, Yeh, Yung-Sung, Li, Ching-Chun, Chen, Yen-Cheng, Su, Wei-Chih, Chang, Tsung-Kun, Huang, Ching-Wen, Huang, Chun-Ming, Tsai, Hsiang-Lin, Wang, Jaw-Yuan
Publicado 2023